<DOC>
	<DOCNO>NCT01959503</DOCNO>
	<brief_summary>This study conduct evaluate safety effectiveness Progel Vascular Sealant use vascular reconstruction achieve adjunctive hemostasis mechanically seal area leakage .</brief_summary>
	<brief_title>Progel Vascular Sealant</brief_title>
	<detailed_description>The primary objective clinical study compare time hemostasis aortic anastomotic suture line subject receive Progel ( Test group ) subject receive Gelfoam Plus ( Control group ) anastomotic suture line involve aortic valve , ascend aorta , aortic arch cardiopulmonary bypass . The primary endpoint study time achieve hemostasis aortic anastomotic suture line time surgical clamp release cessation leakage treat anastomotic site either Progel ( Test ) Gelfoam Plus ( Control ) .</detailed_description>
	<mesh_term>Disease</mesh_term>
	<mesh_term>Aneurysm</mesh_term>
	<mesh_term>Aortic Valve Stenosis</mesh_term>
	<mesh_term>Aortic Aneurysm</mesh_term>
	<mesh_term>Gelatin Sponge , Absorbable</mesh_term>
	<criteria>1 . Subject must ≥ 18 year age . 2 . Subject schedule elective , primary thoracic surgery involve aortic valve , ascend aorta , aortic arch cardiopulmonary bypass . 3 . Subject expect life expectancy &gt; 6 month . 4 . Subject willing able comply aspect study include followup schedule . 5 . Subject authorized representative , ability provide voluntary write informed consent . Intraoperative 1 . Subject able undergo antegrade cardioplegia injection evaluation leak aortic anastomotic site ( ) procedure . 2 . Following injection , subject leak site topical sealant/hemostatic agent may use control bleed . 1 . Subject Type A acute thoracic aortic dissection . 2 . Subject undergone prior thoracic surgery ( open thoracotomy include interventional cardiology procedure ) . 3 . Subject undergoing plan concomitant procedure coronary artery bypass graft ( CABG ) . 4 . Subject previous organ transplant . 5 . Subject know suspected preoperative coagulation disorder . 6 . Subject allergic human thrombin history allergic reaction application human thrombin . 7 . Subject allergic protamine . 8 . Subject Left Ventricular Assist Device ( LVAD ) plan receive LVAD . 9 . Subject undergoing emergency surgery . 10 . Subject chronic renal failure . 11 . Subject hematocrit &lt; 21 % preoperatively . 12 . Subject serum creatinine ≥2.5 mg/dl baseline currently dialysis . 13 . Subject cardiac ejection fraction &lt; 25 % . 14 . Subject schedule another cardiac surgery within 30 day enrollment . 15 . Subject active latent infection systemic intend surgery site . 16 . Subject immunocompromised result chronic oral steroid use , chemotherapeutic agent , immune deficiency disorder . 17 . Subject pregnant positive pregnancy test plan become pregnant study period currently breastfeed . 18 . Subject unwilling receive blood product . 19 . Subject participate another investigational research study within 30 day enrollment . 20 . In opinion investigator , subject clinical condition would preclude use study device , preclude subject complete followup requirement , would complicate evaluation study .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2017</verification_date>
	<keyword>Aorta</keyword>
	<keyword>Aortic</keyword>
	<keyword>Reconstruction</keyword>
	<keyword>CABG</keyword>
	<keyword>Bypass</keyword>
</DOC>